{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:46:14Z","timestamp":1761965174634,"version":"3.37.3"},"reference-count":8,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1136\/annrheumdis-2020-217665","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T21:29:26Z","timestamp":1589405366000},"page":"e22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["No evidence so far on the protective effect of hydroxychloroquine to prevent COVID-19: comment by Joob and Wiwanitkit"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5603-9436","authenticated-orcid":false,"given":"Vasco C.","family":"Rom\u00e3o","sequence":"first","affiliation":[]},{"given":"Ana Rita","family":"Cruz-Machado","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Eurico","family":"Fonseca","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2020-217665_bib1","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1136\/annrheumdis-2020-217506","article-title":"Sle, hydroxychloroquine and NO SLE patients with COVID-19: a comment","volume":"79","author":"Joob","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-217665_bib2","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/annrheumdis-2020-217424","article-title":"Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies","volume":"79","author":"Monti","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-217665_bib3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/annrheumdis-2020-217367","article-title":"To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic","volume":"79","author":"Spinelli","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-217665_bib4","first-page":"105949","article-title":"Does hydroxychloroquine prevent the transmission of covid-19?","volume":"0","author":"Heldwein","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-217665_bib5","first-page":"1","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"2","author":"Yao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1136\/annrheumdis-2020-217665_bib6","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"105949","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1136\/annrheumdis-2020-217665_bib7","article-title":"The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic","volume":"39","author":"Robinson","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/annrheumdis-2020-217665_bib8","first-page":"19","article-title":"Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries","volume":"9913","author":"Gianfrancesco","year":"2020","journal-title":"Lancet Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724010823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724010823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2020-217665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T04:43:26Z","timestamp":1737348206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724010823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0003496724010823"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2020-217665","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No evidence so far on the protective effect of hydroxychloroquine to prevent COVID-19: comment by Joob and Wiwanitkit","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2020-217665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2020-217695","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 \u00a9 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}